117 related articles for article (PubMed ID: 10731436)
21. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity.
Ruggiero A; Chen SN; Lombardi R; Rodriguez G; Marian AJ
Cardiovasc Res; 2013 Jan; 97(1):44-54. PubMed ID: 22987565
[TBL] [Abstract][Full Text] [Related]
23. Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.
Moore RK; Abdullah S; Tardiff JC
Arch Biochem Biophys; 2014 Jun; 552-553():21-8. PubMed ID: 24480310
[TBL] [Abstract][Full Text] [Related]
24. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
Amano K; Sakamoto T; Sugimoto T
J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
[TBL] [Abstract][Full Text] [Related]
25. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
Marian AJ; Roberts R
Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
[TBL] [Abstract][Full Text] [Related]
26. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
[TBL] [Abstract][Full Text] [Related]
27. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
[TBL] [Abstract][Full Text] [Related]
28. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
[TBL] [Abstract][Full Text] [Related]
29. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy.
Nakajima-Taniguchi C; Matsui H; Fujio Y; Nagata S; Kishimoto T; Yamauchi-Takihara K
J Mol Cell Cardiol; 1997 Feb; 29(2):839-43. PubMed ID: 9140840
[TBL] [Abstract][Full Text] [Related]
30. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
[TBL] [Abstract][Full Text] [Related]
31. 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation.
Chen Y; Zhang Z; Hu F; Yang W; Yuan J; Cui J; Hao S; Hu J; Zhou Y; Qiao S
J Steroid Biochem Mol Biol; 2015 Mar; 147():92-102. PubMed ID: 25541436
[TBL] [Abstract][Full Text] [Related]
32. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein.
Redwood C; Lohmann K; Bing W; Esposito GM; Elliott K; Abdulrazzak H; Knott A; Purcell I; Marston S; Watkins H
Circ Res; 2000 Jun; 86(11):1146-52. PubMed ID: 10850966
[TBL] [Abstract][Full Text] [Related]
33. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of serum cardiac troponins T and I to predict cardiac molecular changes and cardiac damage in patients with hypertrophic cardiomyopathy.
Okamoto R; Hirashiki A; Cheng XW; Yamada T; Shimazu S; Shinoda N; Okumura T; Takeshita K; Bando Y; Kondo T; Murohara T
Int Heart J; 2013; 54(4):202-6. PubMed ID: 23924931
[TBL] [Abstract][Full Text] [Related]
36. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.
Marian AJ; Senthil V; Chen SN; Lombardi R
J Am Coll Cardiol; 2006 Feb; 47(4):827-34. PubMed ID: 16487852
[TBL] [Abstract][Full Text] [Related]
37. cTnT1, a cardiac troponin T isoform, decreases myofilament tension and affects the left ventricular pressure waveform.
Nassar R; Malouf NN; Mao L; Rockman HA; Oakeley AE; Frye JR; Herlong JR; Sanders SP; Anderson PA
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1147-56. PubMed ID: 15513965
[TBL] [Abstract][Full Text] [Related]
38. Modifications of Sarcoplasmic Reticulum Function Prevent Progression of Sarcomere-Linked Hypertrophic Cardiomyopathy Despite a Persistent Increase in Myofilament Calcium Response.
Chowdhury SAK; Warren CM; Simon JN; Ryba DM; Batra A; Varga P; Kranias EG; Tardiff JC; Solaro RJ; Wolska BM
Front Physiol; 2020; 11():107. PubMed ID: 32210830
[TBL] [Abstract][Full Text] [Related]
39. [Left ventricular radial and longitudinal systolic function derived from magnetic resonance imaging in hypertrophic cardiomyopathy patients].
Mu L; Li W; Zhu L; Tian X; Su K; Guo Y; Pu Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):661-4. PubMed ID: 25388339
[TBL] [Abstract][Full Text] [Related]
40. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.
Vikstrom KL; Factor SM; Leinwand LA
Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
